MIJ is pleased to announce that our investee company Modalis Therapeutics Corporation was listed on the TSE Mothers Market on August 3, 2020.

This listing is certain to further accelerate R&D utilizing non-cleaving CRISPER technology, which is Modalis’s platform technology, thereby solidifying the company’s growth even more. It is MIJ’s hope that therapies utilizing this innovative technology can be provided to patients who need them as soon as possible.